Notice2022-24610
Charter Renewal of the Advisory Committee on Blood and Tissue Safety and Availability
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 10, 2022
Issuing agencies
Health and Human Services Department
Abstract
The Department of Health and Human Services is hereby giving notice that the charter for the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) has been renewed.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 217 (Thursday, November 10, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 217 (Thursday, November 10, 2022)]
[Notices]
[Pages 67920-67921]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-24610]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Charter Renewal of the Advisory Committee on Blood and Tissue
Safety and Availability
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services is hereby giving
notice that the charter for the Advisory Committee on Blood and Tissue
Safety and Availability (ACBTSA) has been renewed.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Tower Building, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: (202) 795-7608. Email: <a href="/cdn-cgi/l/email-protection#64252726303725240c0c174a030b12"><span class="__cf_email__" data-cfemail="2e6f6d6c7a7d6f6e46465d00494158">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The ACBTSA is a non-discretionary federal
advisory committee. The ACBTSA is authorized under 42 U.S.C. 217a,
Section 222 of the Public Health Service (PHS) Act, as amended. The
Committee is governed by the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C. App),
which sets forth standards for the formation and use of advisory
committees. The ACBTSA advises, assists, consults with, and makes
policy recommendations to the Secretary, through the Assistant
Secretary for Health, regarding broad responsibilities related to the
safety of blood, blood products, tissues, and organs. For solid organs
and blood stem cells, the Committee's work is limited to policy issues
related to donor derived
[[Page 67921]]
infectious disease complications of transplantation.
To carry out its mission, the ACBTSA provides advice to the
Secretary through the Assistant Secretary for Health on a range of
policy issues which includes: (1) identification of public health
issues through surveillance of blood and tissue safety issues with
national biovigilance data tools; (2) identification of public health
issues that affect availability of blood, blood products, and tissues;
(3) broad public health, ethical, and legal issues related to the
safety of blood, blood products, and tissues; (4) the impact of various
economic factors (e.g., product cost and supply) on safety and
availability of blood, blood products, and tissues; (5) risk
communications related to blood transfusion and tissue transplantation;
and (6) identification of infectious disease transmission issues for
blood, organs, blood stem cells and tissues.
On September 29, 2022, the Secretary approved for the ACBTSA
charter to be renewed. The new charter was filed with the appropriate
Congressional committees and the Library of Congress on October 9,
2022. Renewal of the Committee's charter gives authorization for the
Committee to continue to operate until October 9, 2024.
A copy of the ACBTSA charter is available on the Committee's
website at <a href="https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/charter/index.html">https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/charter/index.html</a>.
Dated: November 2, 2022.
James J. Berger,
DFO, Advisory Committee on Blood and Safety and Availability, Office of
HIV/AIDS and Infectious Disease Policy.
[FR Doc. 2022-24610 Filed 11-9-22; 8:45 am]
BILLING CODE 4150-41-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 10, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.